News
A second patient with Duchenne muscular dystrophy has died from acute liver failure after receiving the gene therapy Elevidys ...
The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...
Shares of gene editing companies were largely steady in the premarket on Friday after the FDA’s Center for Biologics Research ...
Another patient has died from acute liver failure after receiving Sarepta’s gene therapy for DMD ; After a quiet start to the ...
Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 44.4% in the afternoon session after the company reported a ...
Sarepta Therapeutics ( NASDAQ: SRPT) fell ~38% in the premarket on Monday after the company reported a second fatality from ...
4d
Stocktwits on MSNSarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off RiskRetail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results